TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway

Cell & Bioscience

Table 2 Relationship between TMED3 expression and tumor characteristics in patients with malignant melanoma

Features	No. of cases	TMED3 expression		P value
Features	No. of cases	low	high	P value
All cases	167	80	87
Age (years)				0.931
≤ 5	85	41	44
> 55	82	39	43
Gender				0.972
Male	90	43	47
Female	77	37	40
Tumor infiltrate				0.343
T2	6	3	3
T3	26	9	17
T4	74	36	38
lymphatic metastasis (N)				0.014
N0	94	46	48
N1	10	2	8
N2	4	0	4
Stage				0.012
I	6	3	3
II	84	43	41
III	12	2	10
IV	4	0	4

ISSN: 2045-3701